Suchergebnisse - "Rosella, Ourania"

PubPharm (25)

1

Vedolizumab and Ustekinumab Levels in Pregnant Women With Inflammatory Bowel Disease and Infants Exposed In Utero

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2024

von Prentice, R. | Flanagan, E. | Wright, E. | +15

2

Pharmacist-Driven Therapeutic Infliximab Monitoring at the Point of Care Using Rapidly Assessed Drug Levels in Patients with Inflammatory Bowel Disease

enthalten in: Therapeutic drug monitoring | 2023

von Rentsch, C. | Ward, M. | Luber, R. | +9

3

Timing of Live Attenuated Vaccination in Infants Exposed to Infliximab or Adalimumab in Utero : A Prospective Cohort Study in 107 Children

enthalten in: Journal of Crohn's & colitis | 2022

von Liu, Z. | Julsgaard, M. | Zhu, X. | +30

4

Ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in utero

enthalten in: Alimentary pharmacology & therapeutics | 2022

von Flanagan, E. | Prentice, R. | Wright, E. | +9

CommentIn: Aliment Pharmacol Ther. 2022 Feb;55(4):495-496. - PMID 35092058

5

Accuracy of Gastrointestinal Ultrasound and Calprotectin in the Assessment of Inflammation and its Location in Patients with an Ileoanal Pouch

enthalten in: Journal of Crohn's & colitis | 2022

von Ardalan, Z. | Friedman, A. | Con, D. | +9

6

Ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in utero

enthalten in: Alimentary Pharmacology & Therapeutics | 2022

von Flanagan, E. | Prentice, R. | Wright, E. | +9

7

Comparison of SB2-Infliximab With Originator-Infliximab in the Measurement of Serum Concentrations : A Short Communication

enthalten in: Therapeutic drug monitoring | 2021

von Ward, M. | Rosella, O. | Rosella, G. | +2

8

Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Flanagan, E. | Gibson, P. | Wright, E. | +19

9

Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure

enthalten in: Alimentary Pharmacology & Therapeutics | 2020

von Flanagan, E. | Gibson, P. | Wright, E. | +18

10

Letter : vedolizumab drug concentrations in neonates following intrauterine exposure

enthalten in: Alimentary pharmacology & therapeutics | 2018

von Flanagan, E. | Gibson, P. | Begun, J. | +6

CommentOn: Aliment Pharmacol Ther. 2017 Apr;45(7):941-950. - PMID 28169436